insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 $
arrow_downward
-4,09%(-0,070) 1D
1,66 $
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Nacionale
·
19 րոպե առաջ
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Yahoo Finance
·
57 րոպե առաջ
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
18 րոպե առաջ
The S&P 500 Is Having the Longest Losing Streak Since February 2020
cwibc.co.id
·
1 ժամ առաջ
S&P 500 Tech Sector Falls 23% Into Bear Market
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc